DFPG Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
MTWSIF
CCP
BCI
22CM
OPS
DFPG Investments's PPH Position: Q4 2020 in Review
DFPG Investments sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2020, closing a stake of 16,613 shares — an estimated $1.03M sold.
DFPG Investments first reported a position in PPH in Q1 2020 and held it in 3 quarters. The position peaked at $1.03M in Q3 2020. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2020.
- DFPG Investments reported no remaining VanEck Pharmaceutical ETF position as of Q4 2020 after selling out during the quarter.
- DFPG Investments sold 16,613 VanEck Pharmaceutical ETF shares in Q4 2020, an estimated $1.03M.
- DFPG Investments first reported a position in VanEck Pharmaceutical ETF in Q1 2020 and held it in 3 quarters.
- DFPG Investments's VanEck Pharmaceutical ETF position peaked at $1.03M in Q3 2020.
- 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2020.
Based on DFPG Investments's 13F filing for Q4 2020, filed 19 Jan 2021.